France· FR:61490953
OMEPRAZOLE CRISTERS LAB 20 mg, gélule gastro-résistante
A omeprazole product containing oméprazole, registered in France by SUN PHARMA FRANCE, on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Omeprazole is registered in 19 of 19 countries.
Countries holding a registration under ATC A02BC01 (omeprazole), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Omeprazole · ATC A02BC01
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of omeprazole costs, country by country.
Normalised to the WHO defined daily dose (20 mg), the median price runs from $0.10 in Spain to $1.17 in Switzerland — a ×12 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Omeprazole · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.17
- IT Italy$0.46
- ES Spain$0.10
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OMÉPRAZOLE
- Manufacturer
- SUN PHARMA FRANCE
- Country
- France (FR)
- ATC code
- A02BC01
- ATC class
- Omeprazole
- Defined daily dose
- 20 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 3
3 priced- cip133400926953775flacon(s) polyéthylène haute densité (PEHD) de 7 gélule(s)EUR 0.95
- cip133400926954086flacon(s) polyéthylène haute densité (PEHD) de 14 gélule(s)EUR 1.59
- cip133400926954376flacon(s) polyéthylène haute densité (PEHD) de 28 gélule(s)EUR 2.85
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
802 interactions on record for omeprazole.
Graded by severity as the source publishes them — 25 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Omeprazole · interactions on record
802 records
- 25 severe
- 136 moderate
- 62 minor
- 568 info
Most severe, free to view
- ClopidogrelB01AC04severe
- CilostazolB01AC23severe
- NelfinavirJ05AE04severe
- AtazanavirJ05AE08severe
11 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Omeprazole in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAcid ReducerLEADER/ Cardinal Health 110, Inc.
- ItalyANADIRS.F. GROUP S.R.L.
- SpainARAPRIDE 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFGArafarma Group S.A.
- United KingdomLosec 20mg gastro-resistant capsulesWaymade Healthcare Plc
- PolandAgastin 20 mgExeltis Poland Sp. z o.o.
- BelgiumAcidcare 20 mgSandoz
- SwedenLosec 20 mg Enterokapsel, hårdMedartuum AB
- NetherlandsLivsane Maagzuurremmende capsules Omeprazol 20 mg, maagsapresistente capsules, hardCentrafarm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Losec, Omec
- Belgium · Acidcare, Lappoxo
- Bulgaria · Probitor, Биопразол
- Cyprus · Ezipol, Medoprazole
- Czechia · Helicid, Helicid Neo
- Germany · Antra Mups, Gastrobin Protect
- Denmark · Lappoxo, Losec
- Estonia · Gasec Gastrocaps, Lappoxo
- Spain · Arapride, Aulcer
- Finland · Losec, Losec Mups
- United Kingdom (Northern Ireland) · Aylome, Boots One-A-Day Acid Reflux Relief
- Greece · Alevior, Assoprol
- Croatia · Lappoxo, Ortalox
- Hungary · Helant, Lappoxo
- Ireland · Appizped, Losec Control
- Iceland · Omeprazol Actavis, Omeprazol Medical Valley
- Italy · Anadir, Antra
- Lithuania · Gasec, Lappoxolo
- Luxembourg · Losec-Mups, Omeprazol Nt Ratiopharm
- Latvia · Gasec Gastrocaps, Lappoxo
- Malta · Losec Control, Losec Mups
- Netherlands · Appizmit, Kruidvat Maagzuurremmer
- Norway · Lappoxo, Losec Mups
- Poland · Agastin 20 Mg, Apteo Med
- Portugal · Albosan, Gasec
- Romania · Helant, Lappoxo
- Sweden · Appizmit, Helicid
- Slovenia · Lappoxo, Ortanol
- Slovakia · Helicid, Helicid Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d249e237-44c1-4e54-8ea2-9f5305125825 GET /v1/drugs/d249e237-44c1-4e54-8ea2-9f5305125825?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61490953",
"date_amm": "2013-07-26",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "OMÉPRAZOLE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation archivée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule gastro-résistant(e)",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about omeprazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.